Summit Trail Advisors, LLC Cytokinetics Inc Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$6.4 - $9.85 $11,328 - $17,434	-1,770 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$6.9 - $9.9 $96,137 - $137,936	-13,933 Reduced 88.73%	1,770 $15,000
Q1 2018 May 21, 2018	BUY	$7.2 - $10.05 $100,965 - $140,931	14,023 Added 834.7%	15,703 $16,000
Q4 2017 Feb 14, 2018	BUY	$7.25 - $15.65 $12,180 - $26,292	1,680	1,680 $16,000

407

125M

4.52M

2.28M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.15B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.